未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINEzanubrutinib与ibrutinib在中国复发/难治性慢性淋巴细胞白血病 (R/R CLL) 患者中的疗效和安全性得到改善: 高山亚组
Zhou, Keshu; Wang, Tingyu; Pan, Ling; Xu, Wei; Jin, Jie; Zhang, Wei; Hu, Yu; Hu, Jianda; Feng, Ru; Li, Ping; Liu, Zhougang; Liu, Peng; Jing, Hongmei; Gao, Sujun; Zhang, Huilai; Yu, Kang; Wang, Zhao; Zhu, Xiongpeng; Sun, Zimin; Li, Fei; Yan, Dongmei; Weng, Jianyu; Fu, Lina; Wang, Liping; Salmi, Tommi; Wu, Kenneth; Qiu, Lugui
分享
收藏
分享
收藏
分享
收藏
分享
收藏Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment
Brown, Jennifer R.; Eichhorst, Barbara; Hillmen, Peter; Jurczak, Wojciech; Kazmierczak, Maciej; Lamanna, Nicole; O'Brien, Susan M.; Tam, Constantine S.; Qiu, Lugui; Zhou, Keshu; Simkovic, Martin; Mayer, Jiri; Gillespie-Twardy, Amanda; Ferrajoli, Alessandra; Ganly, Peter S.; Weinkove, Robert; Grosicki, Sebastian; Mital, Andrzej; Robak, Tadeusz; Osterborg, Anders; Yimer, Habte A.; Salmi, Tommi; Wang, Megan-Der-Yu; Fu, Lina; Li, Jessica; Wu, Kenneth; Cohen, Aileen; Shadman, Mazyar
分享
收藏Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic LeukemiaZanubrutinib或Ibrutinib治疗复发或难治性慢性淋巴细胞白血病
Brown, J. R.; Eichhorst, B.; Hillmen, P.; Jurczak, W.; Kazmierczak, M.; Lamanna, N.; O'Brien, S. M.; Tam, C. S.; Qiu, L.; Zhou, K.; Simkovic, M.; Mayer, J.; Gillespie-Twardy, A.; Ferrajoli, A.; Ganly, P. S.; Weinkove, R.; Grosicki, S.; Mital, A.; Robak, T.; Osterborg, A.; Yimer, H. A.; Salmi, T.; Wang, M. -D. -Y.; Fu, L.; Li, J.; Wu, K.; Cohen, A.; Shadman, M.
分享
收藏
分享
收藏
分享
收藏